Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GGT1 | P19440 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28628528 | 0.88 | MAPT (0.66) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL29670258 | 0.88 | ELANE (0.64) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL474811 | 0.88 | ELANE (0.64) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL10662113 | 0.85 | ELANE (0.57) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL8989321 | 0.83 | MAPT (0.43) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL15496050 | 0.83 | KMT2A (0.43) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL9851284 | 0.82 | MAPT (0.46) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL5506364 | 0.82 | ELANE (0.57) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL28273804 | 0.82 | TDP1 (0.49) | ELANEMAPTKDM4EHSD17B10MAPK1 | |
| SCHEMBL6928775 | 0.81 | ELANE (0.56) | ELANEMAPTKDM4EHSD17B10MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111201253-B | Vinyl chloride-based resin composition and method for preparing the same | 韩华思路信(株) | 2022-05-24 | — | — | CN | claimed |
| US-10829710-B2 | Slipperiness-imparting agent and slipperiness-imparting method | NOF CORPORATION (JP) | 2020-11-10 | — | — | US | claimed |
| CN-111201253-A | Vinyl chloride-based resin composition and method for preparing the same | 韩华思路信(株) | 2020-05-26 | — | — | CN | claimed |
| US-20160194424-A1 | MONOMERS FOR USE IN A POLYMERIZABLE COMPOSITION AND HIGH REFRACTIVE INDEX POLYMER FOR OPTHALMIC APPLICATIONS | CONTAMAC LIMITED (GB) | 2016-07-07 | — | — | US | claimed |
| US-20080031918-A1 | BARRIERS FOR POLYMERIC COATINGS | SURMODICS, INC. | 2008-02-07 | — | — | US | claimed |
| EP-1567203-B1 | BARRIERS FOR BIOACTIVE AGENT-CONTAINING POLYMERIC COATINGS | SURMODICS INC (US) | 2007-09-26 | — | — | EP | claimed |
| JP-3954616-B2 | — | — | 2007-08-08 | — | — | JP | claimed |
| US-7097850-B2 | Bioactive agent release coating and controlled humidity method | SURMODICS, INC. (US) | 2006-08-29 | — | — | US | claimed |
| EP-1551469-B1 | BIOACTIVE AGENT RELEASE COATING WITH AROMATIC POLY(METH)ACRYLATES | SURMODICS INC (US) | 2006-03-08 | — | — | EP | claimed |
| JP-2006505303-A | — | — | 2006-02-16 | — | — | JP | claimed |
| US-20040111144-A1 | Barriers for polymeric coatings | Surmodics Coatings, LLC | 2004-06-10 | — | — | US | claimed |
| WO-2003105920-A1 | METHOD AND SYSTEM FOR PROVIDING BIOACTIVE AGENT RELEASE COATING | SURMODICS, INC. (US) | 2003-12-24 | — | — | WO | claimed |
| WO-2003105918-A1 | BIOACTIVE AGENT RELEASE COATING WITH AROMATIC POLY(METH)ACRYLATES | SURMODICS, INC. (US) | 2003-12-24 | — | — | WO | claimed |
| WO-2003105919-A1 | BIOACTIVE AGENT RELEASE COATING AND CONTROLLED HUMIDITY METHOD | SURMODICS, INC. (US) | 2003-12-24 | — | — | WO | claimed |
| US-20030232087-A1 | Bioactive agent release coating with aromatic poly(meth)acrylates | Surmodics Coatings, LLC | 2003-12-18 | — | — | US | claimed |
| US-20030232122-A1 | Bioactive agent release coating and controlled humidity method | Surmodics Coatings, LLC | 2003-12-18 | — | — | US | claimed |
| US-20020188037-A1 | Method and system for providing bioactive agent release coating | Surmodics Coatings, LLC | 2002-12-12 | — | — | US | claimed |
| EP-0869138-B1 | NOVEL COPOLYMERS FORMED FROM THREE COMPONENTS AND INTRAOCULAR LENSES MADE THEREOF | SANTEN PHARMACEUTICAL CO LTD (JP) | 2002-08-07 | — | — | EP | claimed |
| US-6132462-A | HYDROXYALKYL (ALKYL)ACRYLATE; PYRROLIDONE-CONTAINING ACRYLIC ESTER, AMIDE, OR IMIDE; AND A LOWER ALKYL (ALKYL)ACRYLATE TERPOLYMER; FOLDABLE LENSE HAVING GIVEN REFRACTIVE INDEX, RECOVERY SPEED FROM FOLD STATE AND TENSILE STRENGTH | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2000-10-17 | — | — | US | claimed |
| EP-0869138-A1 | NOVEL COPOLYMERS FORMED FROM THREE COMPONENTS AND INTRAOCULAR LENSES MADE THEREOF | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1998-10-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194424-A1 | MONOMERS FOR USE IN A POLYMERIZABLE COMPOSITION AND HIGH REFRACTIVE INDEX POLYMER FOR OPTHALMIC APPLICATIONS | NR2E3, NR1I2, NR1I3 | ELANE 2093/4885MAPT 2463/4885KDM4E 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.